[Hemochromatosis and myocardial disease : beneficial role of iron depletion (author's transl)].
作者信息
Leclercq J F, Passa P, Warnet A, Azancot I, Coumel P, Slama R
出版信息
Ann Cardiol Angeiol (Paris). 1980 Jun;29(4):291-5.
PMID:7447347
Abstract
摘要
相似文献
1
[Hemochromatosis and myocardial disease : beneficial role of iron depletion (author's transl)].血色素沉着症与心肌病：铁耗竭的有益作用（作者译）
Ann Cardiol Angeiol (Paris). 1980 Jun;29(4):291-5.
2
[Myocardiopathy caused by iron storage. Hemodynamic pattern].[铁储存所致心肌病。血流动力学模式]
Rev Esp Cardiol. 1983;36(5):417-9.
3
Reversible cardiomyopathy associated with hemochromatosis.与血色素沉着症相关的可逆性心肌病。
N Engl J Med. 1972 Oct 26;287(17):866-7. doi: 10.1056/NEJM197210262871708.
4
Cardiac hemochromatosis: beneficial effects of iron removal therapy. An echocardiographic study.
Am J Cardiol. 1983 Oct 1;52(7):824-9. doi: 10.1016/0002-9149(83)90422-8.
5
[Treatment and prevention of chronic iron overload (author's transl)].慢性铁过载的治疗与预防（作者译）
Gastroenterol Clin Biol. 1981 Dec;5(12):1108-19.
6
[Long term results of the treatment of hemochromatosis by repeated bloodletting. Apropos of the article of F. Darnis, A. Mossé and collaborators].[反复放血治疗血色素沉着症的长期结果。关于F. 达尼斯、A. 莫塞及其合作者的文章]
Ann Med Interne (Paris). 1971 Dec;122(12):1211-2.
7
Hypogonadal-induced anemia in genetic hemochromatosis: implications for phlebotomy therapy.遗传性血色素沉着症中低促性腺激素诱导的贫血：对放血疗法的影响。
Am J Gastroenterol. 1995 Jan;90(1):152-3.
8
[The treatment of idiopathic hemochromatosis by means of blood removal and chelates (author's transl)].通过放血和螯合剂治疗特发性血色素沉着症（作者译）
Cas Lek Cesk. 1974 Apr 19;113(15):465-9.
9
[Hemochromatosis (apropos of 100 cases)].[血色素沉着症（关于100例）]
Ann Biol Clin (Paris). 1972;30(4):349-78.
10
[Present aspects of the treatment of hemochromatosis (apropos of 100 observations)].[血色素沉着症的治疗现状（基于100例观察）]
Ann Med Interne (Paris). 1971 Dec;122(12):1193-210.
Zotero 插件